Germany’s partial cannabis legalization backfired, fueling smuggling instead of weakening the black market. In 2024, seizures rose sharply: 12.6 tons of marijuana (+50%), alongside large amounts...
Seven years after legalization, Canada achieved its goal: nearly 80% of cannabis sales now come from legal stores. Initially dominated by the black market, progress came...
The Trump administration is weighing up cannabis reclassification, moving it from Schedule I to a lower classification. This could potentially ease taxes, open banking access, and...
China has overtaken the U.S. in new pharmaceutical innovation after leading the world in new drug discoveries in 2024, with 28 new molecules discovered. Although it...
Colombia plans to regulate cannabis-derived medications, allowing pharmacies to sell controlled-dose forms like tablets and creams. Only authorized pharmacies may prepare custom prescriptions. Agencies will oversee...
Hesse’s slow cannabis club licensing—averaging nine months—frustrates applicants and burdens clubs financially. Many fail due to bureaucracy, high costs, and unclear rules. Despite legalization, access remains...
Kazakhstan has legalized low-THC hemp cultivation, aiming to produce high-security paper for export. Strict regulations limit THC to 0.3%. Production will center in North Kazakhstan, with...
Medical cannabis imports in Germany have surged, but health insurance-covered prescriptions remain low. Easy online access raises concerns about abuse and bypassing doctor contact. Proposed reforms...
Germany plans stricter rules for medical cannabis: prescriptions will require in-person doctor visits, banning video consultations and mail-order delivery. Sales will be limited to pharmacies to...
Switzerland is moving toward cannabis legalization with a public health-focused bill. Adults could buy certified marijuana from licensed outlets, grow up to three plants, and face...